Renaissance Capital logo

TRHC News

US IPO Weekly Recap: Nutanix skyrockets 131% in year's best IPO debut

NTNX

The third quarter finished with the year's best first-day pop as Nutanix spiked 131% on Friday. September ended as the most active month of 2016 both in terms of IPO pricings (16) and initial filings (18). Nutanix's incredible first-day performance was a fitting end to a quarter marked by the return of tech IPOs and 41% average returns. ...read more

Behind the PACE: Tabula Rasa HealthCare prices IPO at $12, below the range

TRHC

Tabula Rasa HealthCare, which provides e-prescription fulfillment and medication risk management services, raised $52 million by offering 4.3 million shares at $12, below the range of $13 to $15. Tabula Rasa HealthCare plans to list on the Nasdaq under the symbol TRHC. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as lead managers on the deal....read more

US IPO Week Ahead: Year's largest US tech company to IPO, Nutanix, leads 5-deal week

NTNX

Five IPOs are scheduled to close out the third quarter, putting September on pace to be the year's most active month for IPOs. Nutanix's highly-anticipated IPO will get the most attention, given its growth, scale, and implications for the massive backlog of Silicon Valley tech IPOs with private valuations of more than $1 billion. The other three notable IPOs this...read more

ADEs prevention for seniors: Tabula Rasa HealthCare sets terms for $60 million IPO

TRHC

Tabula Rasa HealthCare, which provides risk management solutions to reduce adverse drug events (ADEs) at long-term care facilities, announced terms for its IPO on Monday. The Moorestown, NJ-based company plans to raise $60 million by offering 4.3 million shares at a price range of $13 to $15. At the midpoint of the proposed range, Tabula Rasa HealthCare would command a fully...read more